Laheurte et al. describe the properties of UCPVax, a CD4 helper cancer vaccine derived from telomerase that triggers polyfunctional Th1 cells with cytolytic properties, generates robust antibody responses, and promotes strong epitope spreading—factors that contribute to optimal tumor control. Here, CD4 is linked to cancer.